Comparison of cardiovascular prognosis by 3 serum cystatin C methods in the heart and soul study

Clinical Chemistry

Volumn 57, Issue 5, 2011, Pages 737-745

  Shlipak, Michael G ^a,b   Weekley, Cristin C ^a,b   Li, Yongmei ^a   Hansson, Lars Olof ^c   Larsson, Anders ^c   Whooley, Mary ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CHEMISTRY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN DETERMINATION;

BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CYSTATIN C; HUMANS; IMMUNOASSAY; NEPHELOMETRY AND TURBIDIMETRY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SERUM;

GENTIANA;

EID: 79956075538     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.158915     Document Type: Article

References (18)

1. Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 2006;15:610-6. (Pubitemid 44607433)
2. Lofberg H, Grubb AO. Quantitation of gammatrace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 1979;39:619-26. (Pubitemid 10214387)
3. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994;40:1921-6.
4. Grubb A. Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: simultaneous use of cystatin C-and creatinine-based GFRprediction equations, clinical data and an internal quality check. Scand J Clin Lab Invest 2010;70:65-70.
5. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40:221-6. (Pubitemid 34827638)
6. Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008;167:1226-34. (Pubitemid 351670638)
7. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-60. (Pubitemid 40664306)
8. Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, et al. Cystatin C and mortality risk in the elderly: the Health, Aging, and Body Composition Study. J Am Soc Nephrol 2006;17:254-61.
9. Bibbins-Domingo K, Chertow GM, Fried LF, Odden MC, Newman AB, Kritchevsky SB, et al. Renal function and heart failure risk in older black and white individuals: the Health, Aging, and Body Composition Study. Arch Intern Med 2006;166:1396-402. (Pubitemid 44036352)
10. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 2007;147:19-27. (Pubitemid 351664630)
11. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007;115:173-9. (Pubitemid 46105715)
12. Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA. Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the Heart and Soul Study. J Am Soc Nephrol 2003;14:3233-8. (Pubitemid 37509298)
13. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003;290:215-21. (Pubitemid 37430060)
14. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005;37:360-3. (Pubitemid 40656185)
15. Reichenheim M. Confidence intervals for the kappa statistic. Stata J 2004;4:421-8.
16. Newson R. Comparing the predictive power of survival models using Harrell's C or Somer's D. Stata J 2010;10:339-58.
17. Blirup-Jensen S, Grubb A, Lindstrom V, Schmidt C, Althaus H. Standardization of cystatin C: development of primary and secondary reference preparations. Scand J Clin Lab Invest Suppl 2008;241:67-70. (Pubitemid 351883660)
18. Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, Zegers I. First certified reference material for cystatin C in human serum ERMDA471/IFCC. Clin Chem Lab Med 2010;48:1619-21.